We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Blood Sector Continues to Experience Solid Growth

By LabMedica International staff writers
Posted on 10 Nov 2014
Print article
The global blood industry has experienced strong growth in recent years and growth will remain solid though 2018, according to the new report, "Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products," from healthcare market researcher Kalorama Information (New York City, NY, USA).

The market for human blood and blood components continues to expand as a result of growing and aging populations in the US, Europe, and Japan; technology advancements and new products; promotion of blood donation; and in the US via expansion of health coverage. The US is the single largest global market for blood products such as plasma. "The expanded health coverage the Affordable Care Act brings in the US will help to drive the global market," the report stated.

While some countries, such as India and the Philippines, set prices for blood and blood components, in many developed countries (including the US) there is no uniform, fixed price for blood—cost varies from country to country and region to region, with fluctuations often occurring and even nearby centers often charging different prices.

In addition to blood collection, the market includes: blood typing and testing for diseases, blood storage and processing, blood transfusions, blood management and safety issues, synthetic blood products, the blood products market, the blood testing and typing products market, the plasma and blood collection equipment market, and the synthetic blood products market. The Kalorama report provides an analysis of the key market segments involved, including products, equipment, and testing. In addition to complete market data, including forecasts to 2018, the study reports product demand estimates by region, collection and transfusion estimates, high-blood-loss procedure estimates, product pricing, reimbursement rates, and products on market and in development.

Effective management of blood supplies is critical, and the industry continues to be challenged with growth in demand that exceeds increases in supply. The US may be the largest consumer, but demand is high and continues to grow also in other countries, including China, Japan, and Germany.

The report provides discussions of key trends, as well as regulatory, business, and clinical challenges facing the various sectors. It also profiles many key companies in the industry. Estimates are provided for the historic 2008 to 2013 period, and forecasts through 2018. Historical information was gathered from a wide variety of published sources. Interviews were conducted to capture perspectives from industry participants' point of view and assess trends, and form the basis of the forecasting and competitive analysis.

Related Links:

Kalorama Information
Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.